LCC [Liverpool ChiroChem]
Chemistry platform built on proprietary chiral chemical space, progressing hits to small molecule lead candidate assets.
30 employees · est. 2014 · Liverpool, United Kingdom
Protagonist Therapeutics
Develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies
156 employees · est. 2006 · Newark, United States
Protagonist Therapeutics is the older company (2014 vs 2006); Protagonist Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | LCC [Liverpool ChiroChem] | Protagonist Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2006 older |
| Headquarters | ||
| Headquarters | Liverpool, United Kingdom | Newark, United States |
| Employees | ||
| Employees | 30 | 156 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Manufacturing | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | IPO |
| Total Funding | ||
| Total Funding | $5.75M | $537.50M |
| Funding Rounds | ||
| Funding Rounds | 4 | 12 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Chiral Chemistry, Drug Discovery, Chemical Space, Chemical Library, CRO Services, Biotech/Pharmaceutical R&D, Small Molecule Lead Candidates, Chiral Technology, Chemical Building Blocks, Fragment-Based Drug Discovery (FBDD), Virtual Library, Chemical Synthesis, Therapeutic Areas, Asymmetric Hydrogenation, Pd-Coupling | Not tracked yet |
| Website | ||
| Website | liverpoolchirochem.com | protagonist-inc.com |
About LCC [Liverpool ChiroChem]
LCC [Liverpool ChiroChem] is a biotechnology startup leveraging its proprietary chiral chemistry platform to advance small molecule lead candidate assets for the treatment of oncology and rare diseases. Established in 2014, LCC has successfully developed its PACE platform, focusing on component qual...
About Protagonist Therapeutics
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical n...
We will tell you when either one moves
BounceWatch watches LCC [Liverpool ChiroChem] and Protagonist Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at LCC [Liverpool ChiroCh... and Protagonist Therapeuti... — by email.
Frequently Asked Questions
Compare LCC [Liverpool ChiroChem] with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at LCC [Liverpool ChiroChem] on 6 Dec 2024, and Protagonist Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.